PMC10329462_01
The timeline of VRZ treatment process. The dots represent VRZ concentrations in mg/L.
IDR-16-4349-g0001.jpg
PMC10329462_01_IDR-16-4349-g0001.jpg
f0001
Table 1. The dosing regimen and trough concentration changes of VRZ during the treatment are presented in Figure 1.
CT and MRI results of thoracolumbar vertebrae on the second day of hospitalization. (A): CT testing showed destruction of the T11 and T12 vertebral bodies. (B): MRI testing showed infectious lesions in T11-12 vertebral body and the right appendage of T12 (T1 weighted imaging signal was down). (C): MRI testing showed infectious lesions in T11-12 vertebral body and the right appendage of T12 (T2 weighted imaging signal was high). The red arrow showed the destruction of the T11 and T12 vertebral bodies.
IDR-16-4349-g0002.jpg
PMC10329462_01_IDR-16-4349-g0002.jpg
f0002
Radiographic images, including CT scans and MRIs, are shown in Figure 2.